Washington University School of Medicine: Neoplasm Metastasis trials

The registry lists 10 Neoplasm Metastasis studies with Washington University School of Medicine as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 4Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CCR2 PET Imaging Head and Neck Squamous Cell CarcinomaRecruitingNCT07659678Phase 2
• Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain MetastasisTerminatedNCT03903640Phase 2Results posted
• Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)CompletedNCT00823303Phase 4Results posted
• A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control PainTerminatedNCT00802659Not applicableResults posted
• Stereotactic Radiosurgery (SRS) for Spine MetastasesTerminatedNCT00593320Not applicableResults posted
• Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver InvolvementTerminatedNCT00537823Phase 2Results posted
• Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton TherapyActive, not recruitingNCT05831579Not applicable
• Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)WithdrawnNCT05255666Phase 2
• Simulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Cone Beam Computed Tomography-Guided On-Table Adaptive Planning in a Novel Ring Gantry Radiotherapy DeviceCompletedNCT05096286Not applicable
• Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance ImagingCompletedNCT02311556Phase 1